{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T17:37:08Z","timestamp":1774460228364,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:00:00Z","timestamp":1732233600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:00:00Z","timestamp":1732233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s40272-024-00667-1","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T17:02:16Z","timestamp":1732294936000},"page":"247-255","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Dexmedetomidine for Less Invasive Surfactant Administration: A Pilot Study"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7873-5224","authenticated-orcid":false,"given":"Sagee","family":"Nissimov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amitai","family":"Kohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rimona","family":"Keidar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayelet","family":"Livne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mazal","family":"Shemer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayala","family":"Gover","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Calanit","family":"Hershkovich-Shporen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matitiahu","family":"Berkovitch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris","family":"Morag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,22]]},"reference":[{"key":"667_CR1","doi-asserted-by":"publisher","unstructured":"Aldana-Aguirre JC, Pinto M, Featherstone RM, Kumar M. Less invasive surfactant administration versus intubation for surfactant delivery in preterm infants with respiratory distress syndrome: a systematic review and meta-analysis. https:\/\/doi.org\/10.1136\/archdischild-2015-310299","DOI":"10.1136\/archdischild-2015-310299"},{"key":"667_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000528914","volume":"120","author":"DG Sweet","year":"2023","unstructured":"Sweet DG, Carnielli VP, Greisen G, et al. European consensus guidelines on the management of respiratory distress syndrome: 2022 update. Neonatology. 2023;120:3. https:\/\/doi.org\/10.1159\/000528914.","journal-title":"Neonatology"},{"key":"667_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011672.PUB2","author":"ME Abdel-Latif","year":"2021","unstructured":"Abdel-Latif ME, Davis PG, Wheeler KI, et al. Surfactant therapy via thin catheter in preterm infants with or at risk of respiratory distress syndrome. Cochrane Database Syst Rev. 2021. https:\/\/doi.org\/10.1002\/14651858.CD011672.PUB2.","journal-title":"Cochrane Database Syst Rev"},{"key":"667_CR4","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1542\/PEDS.2009-2863","volume":"125","author":"P Kumar","year":"2010","unstructured":"Kumar P, Denson SE, Mancuso TJ, et al. Premedication for nonemergency endotracheal intubation in the neonate. Pediatrics. 2010;125:608\u201315. https:\/\/doi.org\/10.1542\/PEDS.2009-2863.","journal-title":"Pediatrics"},{"key":"667_CR5","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/APA.14606","volume":"108","author":"G Ancora","year":"2019","unstructured":"Ancora G, Lago P, Garetti E, et al. Evidence-based clinical guidelines on analgesia and sedation in newborn infants undergoing assisted ventilation and endotracheal intubation. Acta Paediatr. 2019;108:208\u201317. https:\/\/doi.org\/10.1111\/APA.14606.","journal-title":"Acta Paediatr"},{"key":"667_CR6","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/S41372-019-0367-0","volume":"39","author":"Y Ozawa","year":"2019","unstructured":"Ozawa Y, Ades A, Foglia EE, et al. Premedication with neuromuscular blockade and sedation during neonatal intubation is associated with fewer adverse events. J Perinatol. 2019;39:848\u201356. https:\/\/doi.org\/10.1038\/S41372-019-0367-0.","journal-title":"J Perinatol"},{"key":"667_CR7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/PNE2.12033","volume":"3","author":"A Balakrishnan","year":"2021","unstructured":"Balakrishnan A, Sanghera RS, Boyle EM. New techniques, new challenges\u2014the dilemma of pain management for less invasive surfactant administration? Paediatr Neonatal Pain. 2021;3:2\u20138. https:\/\/doi.org\/10.1002\/PNE2.12033.","journal-title":"Paediatr Neonatal Pain"},{"key":"667_CR8","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1159\/000519283","volume":"118","author":"J Peterson","year":"2021","unstructured":"Peterson J, Den Boer MC, Roehr CC. To sedate or not to sedate for less invasive surfactant administration: an ethical approach. Neonatology. 2021;118:639\u201346. https:\/\/doi.org\/10.1159\/000519283.","journal-title":"Neonatology"},{"key":"667_CR9","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1159\/000521553","volume":"119","author":"S Tribolet","year":"2022","unstructured":"Tribolet S, Hennuy N, Snyers D, et al. Analgosedation before less-invasive surfactant administration: a systematic review. Neonatology. 2022;119:137\u201350. https:\/\/doi.org\/10.1159\/000521553.","journal-title":"Neonatology"},{"key":"667_CR10","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/S41372-022-01351-3","volume":"42","author":"D McDonald","year":"2022","unstructured":"McDonald D, Palsgraf H, Shah P. Dexmedetomidine\u2014an emerging option for sedation in neonatal patients. J Perinatol. 2022;42:845\u201355. https:\/\/doi.org\/10.1038\/S41372-022-01351-3.","journal-title":"J Perinatol"},{"key":"667_CR11","doi-asserted-by":"publisher","first-page":"e2341033","DOI":"10.1001\/JAMANETWORKOPEN.2023.41033","volume":"6","author":"S Curtis","year":"2023","unstructured":"Curtis S, Kilpatrick R, Billimoria ZC, et al. Use of dexmedetomidine and opioids in hospitalized preterm infants. JAMA Netw Open. 2023;6:e2341033\u2013e2341033. https:\/\/doi.org\/10.1001\/JAMANETWORKOPEN.2023.41033.","journal-title":"JAMA Netw Open"},{"key":"667_CR12","doi-asserted-by":"publisher","first-page":"252","DOI":"10.5863\/1551-6776-17.3.252","volume":"17","author":"K O\u2019Mara","year":"2012","unstructured":"O\u2019Mara K, Gal P, Wimmer J, et al. Dexmedetomidine versus standard therapy with fentanyl for sedation in mechanically ventilated premature neonates. J Pediatr Pharmacol Ther. 2012;17:252\u201362. https:\/\/doi.org\/10.5863\/1551-6776-17.3.252.","journal-title":"J Pediatr Pharmacol Ther"},{"key":"667_CR13","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1111\/PAN.14461","volume":"32","author":"N Leister","year":"2022","unstructured":"Leister N, Y\u00fccetepe S, Ulrichs C, et al. Dexmedetomidine as a sole sedative for procedural sedation in preterm and neonate infants: a retrospective analysis. Paediatr Anaesth. 2022;32:907\u201315. https:\/\/doi.org\/10.1111\/PAN.14461.","journal-title":"Paediatr Anaesth"},{"key":"667_CR14","doi-asserted-by":"publisher","first-page":"628","DOI":"10.5863\/1551-6776-28.7.628","volume":"28","author":"J Guillen-Hernandez","year":"2023","unstructured":"Guillen-Hernandez J, Kyllonen KC, Tumin D, Rodriguez RJ. The use of dexmedetomidine in preterm infants: a single academic center experience. J Pediatr Pharmacol Ther. 2023;28:628\u201334. https:\/\/doi.org\/10.5863\/1551-6776-28.7.628.","journal-title":"J Pediatr Pharmacol Ther"},{"key":"667_CR15","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/JP.2017.174","volume":"38","author":"P Chandrasekharan","year":"2018","unstructured":"Chandrasekharan P, Rawat M, Reynolds AM, et al. Apnea, bradycardia and desaturation spells in premature infants\u2014impact of a protocol for duration of \u201cSpell-Free\u201d observation on inter-provider variability and readmission rates. J Perinatol. 2018;38:86. https:\/\/doi.org\/10.1038\/JP.2017.174.","journal-title":"J Perinatol"},{"key":"667_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/FN.80.1.F38","author":"W Tin","year":"1999","unstructured":"Tin W. Systolic blood pressure in babies of less than 32 weeks gestation in the first year of life. Northern Neonatal Nursing Initiative. Arch Dis Child Fetal Neonatal Ed. 1999. https:\/\/doi.org\/10.1136\/FN.80.1.F38.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"667_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/APA.17300","author":"D Vittner","year":"2024","unstructured":"Vittner D, Butler S, Lawhon G, Buehler D. The newborn individualised developmental care and assessment program: a model of care for infants and families in hospital settings. Acta Paediatr. 2024. https:\/\/doi.org\/10.1111\/APA.17300.","journal-title":"Acta Paediatr"},{"key":"667_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/SJ.JP.7211861","volume":"28","author":"P Hummel","year":"2008","unstructured":"Hummel P, Puchalski M, Creech SD, Weiss MG. Clinical reliability and validity of the N-PASS: neonatal pain, agitation and sedation scale with prolonged pain. J Perinatol. 2008;28:55\u201360. https:\/\/doi.org\/10.1038\/SJ.JP.7211861.","journal-title":"J Perinatol"},{"key":"667_CR19","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1159\/000443823","volume":"109","author":"J Dekker","year":"2016","unstructured":"Dekker J, Lopriore E, Rijken M, et al. Sedation during minimal invasive surfactant therapy in preterm infants. Neonatology. 2016;109:308\u201313. https:\/\/doi.org\/10.1159\/000443823.","journal-title":"Neonatology"},{"key":"667_CR20","doi-asserted-by":"publisher","first-page":"4750","DOI":"10.1080\/14767058.2020.1863365","volume":"35","author":"P Krajewski","year":"2022","unstructured":"Krajewski P, Szpecht D, Ho\u017cejowski R. Premedication practices for less invasive surfactant administration\u2014results from a nationwide cohort study. J Matern Fetal Neonatal Med. 2022;35:4750\u20134. https:\/\/doi.org\/10.1080\/14767058.2020.1863365.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"667_CR21","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/S00431-016-2812-9\/METRICS","volume":"176","author":"D Klotz","year":"2017","unstructured":"Klotz D, Porcaro U, Fleck T, Fuchs H. European perspective on less invasive surfactant administration\u2014a survey. Eur J Pediatr. 2017;176:147\u201354. https:\/\/doi.org\/10.1007\/S00431-016-2812-9\/METRICS.","journal-title":"Eur J Pediatr"},{"key":"667_CR22","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1159\/000530333","volume":"120","author":"K Pichler","year":"2023","unstructured":"Pichler K, Kuehne B, Dekker J, et al. Assessment of comfort during less invasive surfactant administration in very preterm infants: a multicenter study. Neonatology. 2023;120:473. https:\/\/doi.org\/10.1159\/000530333.","journal-title":"Neonatology"},{"issue":"3","key":"667_CR23","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41390-022-02121-9","volume":"93","author":"L Moschino","year":"2022","unstructured":"Moschino L, Ramaswamy VV, Reiss IKM, et al. Sedation for less invasive surfactant administration in preterm infants: a systematic review and meta-analysis. Pediatr Res. 2022;93(3):471\u201391. https:\/\/doi.org\/10.1038\/s41390-022-02121-9.","journal-title":"Pediatr Res"},{"key":"667_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/J.NBD.2022.105923","volume":"175","author":"OH Cabrera","year":"2022","unstructured":"Cabrera OH, Useinovic N, Maksimovic S, et al. Neonatal ketamine exposure impairs infrapyramidal bundle pruning and causes lasting increase in excitatory synaptic transmission in hippocampal CA3 neurons. Neurobiol Dis. 2022;175: 105923. https:\/\/doi.org\/10.1016\/J.NBD.2022.105923.","journal-title":"Neurobiol Dis"},{"key":"667_CR25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4103\/JOACP.JOACP_415_19","volume":"37","author":"K Kalopita","year":"2021","unstructured":"Kalopita K, Armakolas A, Philippou A, et al. Ketamine-induced neurotoxicity in neurodevelopment: a synopsis of main pathways based on recent in vivo experimental findings. J Anaesthesiol Clin Pharmacol. 2021;37:37\u201342. https:\/\/doi.org\/10.4103\/JOACP.JOACP_415_19.","journal-title":"J Anaesthesiol Clin Pharmacol"},{"key":"667_CR26","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1053\/J.SEMPERI.2007.07.005","volume":"31","author":"AT Bhutta","year":"2007","unstructured":"Bhutta AT. Ketamine: a controversial drug for neonates. Semin Perinatol. 2007;31:303\u20138. https:\/\/doi.org\/10.1053\/J.SEMPERI.2007.07.005.","journal-title":"Semin Perinatol"},{"key":"667_CR27","doi-asserted-by":"publisher","unstructured":"Barends CRM, Absalom A, van Minnen B, et al. Dexmedetomidine versus midazolam in procedural sedation. A systematic review of efficacy and safety. 2017. https:\/\/doi.org\/10.1371\/journal.pone.0169525.","DOI":"10.1371\/journal.pone.0169525"},{"key":"667_CR28","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1111\/APA.15348","volume":"109","author":"M Tervonen","year":"2020","unstructured":"Tervonen M, Pokka T, Kallio M, Peltoniemi O. Systematic review and meta-analysis found that intranasal dexmedetomidine was a safe and effective sedative drug during paediatric procedural sedation. Acta Paediatr. 2020;109:2008\u201316. https:\/\/doi.org\/10.1111\/APA.15348.","journal-title":"Acta Paediatr"},{"key":"667_CR29","doi-asserted-by":"publisher","unstructured":"Chopra P, Dixit MB, Dang A, Gupta V. Dexmedetomidine provides optimum conditions during awake fiberoptic intubation in simulated cervical spine injury patients. 2016. https:\/\/doi.org\/10.4103\/0970-9185.175666.","DOI":"10.4103\/0970-9185.175666"},{"key":"667_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009798.PUB2","author":"XY He","year":"2014","unstructured":"He XY, Cao JP, He Q, Shi XY. Dexmedetomidine for the management of awake fibreoptic intubation. Cochrane Database Syst Rev. 2014. https:\/\/doi.org\/10.1002\/14651858.CD009798.PUB2.","journal-title":"Cochrane Database Syst Rev"},{"key":"667_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/CHILDREN10030454","author":"L Mantec\u00f3n-Fern\u00e1ndez","year":"2023","unstructured":"Mantec\u00f3n-Fern\u00e1ndez L, Lareu-Vidal S, Gonz\u00e1lez-L\u00f3pez C, et al. Dexmedetomidine: an alternative to pain treatment in neonatology. Children. 2023. https:\/\/doi.org\/10.3390\/CHILDREN10030454.","journal-title":"Children"},{"key":"667_CR32","doi-asserted-by":"publisher","DOI":"10.1055\/S-0038-1669938","volume":"8","author":"K O\u2019Mara","year":"2018","unstructured":"O\u2019Mara K, Weiss MD. Dexmedetomidine for sedation of neonates with HIE undergoing therapeutic hypothermia: a single-center experience. AJP Rep. 2018;8: e168. https:\/\/doi.org\/10.1055\/S-0038-1669938.","journal-title":"AJP Rep"},{"key":"667_CR33","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/530371","author":"M Sifringer","year":"2015","unstructured":"Sifringer M, Von Haefen C, Krain M, et al. Neuroprotective effect of dexmedetomidine on hyperoxia-induced toxicity in the neonatal rat brain. Oxid Med Cell Longev. 2015. https:\/\/doi.org\/10.1155\/2015\/530371.","journal-title":"Oxid Med Cell Longev"},{"key":"667_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/CHILDREN8121145","author":"B Liebers","year":"2021","unstructured":"Liebers B, Ebenebe CU, Wolf M, et al. Improved less invasive surfactant administration success in preterm infants after procedure standardization. Children (Basel). 2021. https:\/\/doi.org\/10.3390\/CHILDREN8121145.","journal-title":"Children (Basel)"},{"key":"667_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/J.EARLHUMDEV.2022.105562","volume":"167","author":"FMS Arattu Thodika","year":"2022","unstructured":"Arattu Thodika FMS, Ambulkar H, Williams E, et al. Outcomes following less-invasive-surfactant-administration in the delivery-room. Early Hum Dev. 2022;167: 105562. https:\/\/doi.org\/10.1016\/J.EARLHUMDEV.2022.105562.","journal-title":"Early Hum Dev"},{"key":"667_CR36","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1001\/JAMAPEDIATRICS.2015.0504","volume":"169","author":"A Kribs","year":"2015","unstructured":"Kribs A, Roll C, G\u00f6pel W, et al. Nonintubated surfactant application vs conventional therapy in extremely preterm infants: a randomized clinical trial. JAMA Pediatr. 2015;169:723\u201330. https:\/\/doi.org\/10.1001\/JAMAPEDIATRICS.2015.0504.","journal-title":"JAMA Pediatr"},{"key":"667_CR37","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1007\/S00431-021-04103-1\/METRICS","volume":"180","author":"C Brotelande","year":"2021","unstructured":"Brotelande C, Mil\u00e9si C, Combes C, et al. Premedication with ketamine or propofol for less invasive surfactant administration (LISA): observational study in the delivery room. Eur J Pediatr. 2021;180:3053\u20138. https:\/\/doi.org\/10.1007\/S00431-021-04103-1\/METRICS.","journal-title":"Eur J Pediatr"},{"key":"667_CR38","doi-asserted-by":"publisher","first-page":"F378","DOI":"10.1136\/ARCHDISCHILD-2018-315015","volume":"104","author":"J Dekker","year":"2019","unstructured":"Dekker J, Lopriore E, Van Zanten HA, et al. Sedation during minimal invasive surfactant therapy: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed. 2019;104:F378\u201383. https:\/\/doi.org\/10.1136\/ARCHDISCHILD-2018-315015.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"667_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/TROPEJ\/FMAC019","volume":"68","author":"H Sk","year":"2022","unstructured":"Sk H, Saha B, Mukherjee S, Hazra A. Premedication with fentanyl for less invasive surfactant application (LISA): a randomized controlled trial. J Trop Pediatr. 2022;68:1\u201311. https:\/\/doi.org\/10.1093\/TROPEJ\/FMAC019.","journal-title":"J Trop Pediatr"},{"key":"667_CR40","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1111\/APA.14317","volume":"107","author":"L Bourgoin","year":"2018","unstructured":"Bourgoin L, Caeymaex L, Decobert F, et al. Administering atropine and ketamine before less invasive surfactant administration resulted in low pain scores in a prospective study of premature neonates. Acta Paediatr. 2018;107:1184\u201390. https:\/\/doi.org\/10.1111\/APA.14317.","journal-title":"Acta Paediatr"},{"key":"667_CR41","doi-asserted-by":"publisher","first-page":"E31306","DOI":"10.1097\/MD.0000000000031306","volume":"101","author":"HJ Kim","year":"2022","unstructured":"Kim HJ, Ahn EJ. Risk factors for dexmedetomidine-associated bradycardia during spinal anesthesia: a retrospective study. Medicine. 2022;101:E31306. https:\/\/doi.org\/10.1097\/MD.0000000000031306.","journal-title":"Medicine"},{"key":"667_CR42","doi-asserted-by":"publisher","first-page":"112","DOI":"10.5863\/1551-6776-20.2.112","volume":"20","author":"LM Estkowski","year":"2015","unstructured":"Estkowski LM, Morris JL, Sinclair EA. Characterization of dexmedetomidine dosing and safety in neonates and infants. J Pediatr Pharmacol Ther. 2015;20:112\u20138. https:\/\/doi.org\/10.5863\/1551-6776-20.2.112.","journal-title":"J Pediatr Pharmacol Ther"},{"key":"667_CR43","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jpeds.2013.10.002","volume":"164","author":"C Chrysostomou","year":"2014","unstructured":"Chrysostomou C, Schulman SR, Herrera Castellanos M, et al. A phase II\/III, multicenter, safety, efficacy, and pharmacokinetic study of dexmedetomidine in preterm and term neonates. J Pediatr. 2014;164:276-282.e3. https:\/\/doi.org\/10.1016\/j.jpeds.2013.10.002.","journal-title":"J Pediatr"},{"key":"667_CR44","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4103\/0970-9185.76610","volume":"27","author":"D \u00d6zcengiz","year":"2011","unstructured":"\u00d6zcengiz D, G\u00fcnes Y, Atci M. Preliminary experience with dexmedetomidine in neonatal anesthesia. J Anaesthesiol Clin Pharmacol. 2011;27:17. https:\/\/doi.org\/10.4103\/0970-9185.76610.","journal-title":"J Anaesthesiol Clin Pharmacol"},{"key":"667_CR45","doi-asserted-by":"publisher","unstructured":"Cohen A, Valda Toro P, Kahn P, et al. Dexmedetomidine-induced thermodysregulation in the Intensive Care Unit. ATS 2020 International Conference American Thoracic Society International Conference Meetings Abstracts A6310\u2013A6310. 2020. https:\/\/doi.org\/10.1164\/AJRCCM-CONFERENCE.2020.201.1_MEETINGABSTRACTS.A6310.","DOI":"10.1164\/AJRCCM-CONFERENCE.2020.201.1_MEETINGABSTRACTS.A6310"},{"key":"667_CR46","doi-asserted-by":"publisher","first-page":"E2674","DOI":"10.1055\/A-2142-9434","volume":"41","author":"S Shetty","year":"2024","unstructured":"Shetty S, Tolentino D, Kulkarni A, et al. Comparison of outcomes of less invasive surfactant administration in prematurely born infants in the delivery suite and the neonatal unit. Am J Perinatol. 2024;41:E2674\u20138. https:\/\/doi.org\/10.1055\/A-2142-9434.","journal-title":"Am J Perinatol"},{"key":"667_CR47","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1007\/S00228-019-02708-Y\/TABLES\/3","volume":"75","author":"SC van Dijkman","year":"2019","unstructured":"van Dijkman SC, De Cock PAJG, Smets K, et al. Dose rationale and pharmacokinetics of dexmedetomidine in mechanically ventilated new-borns: impact of design optimisation. Eur J Clin Pharmacol. 2019;75:1393\u2013404. https:\/\/doi.org\/10.1007\/S00228-019-02708-Y\/TABLES\/3.","journal-title":"Eur J Clin Pharmacol"}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-024-00667-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40272-024-00667-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-024-00667-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T11:18:39Z","timestamp":1739618319000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40272-024-00667-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,22]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["667"],"URL":"https:\/\/doi.org\/10.1007\/s40272-024-00667-1","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,22]]},"assertion":[{"value":"4 November 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial interests to disclose. This research received no specific grant from any funding agency.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Sagee Nissimov, Amitai Kohn, Rimona Keidar, Ayelet Livne, Mazal Shemer, Ayala Gover, Calanit Hershkovich-Shporen, Matitiahu Berkovitch, and Iris Morag declare that they have no potential conflicts of interest that might be relevant to the contents of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Research ethics approval for the study was obtained from Shamir Medical Center in accordance with the Declaration of Helsinki\u00a0(approval number 0056-24-ASF).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Due to the fact that dexmedetomidine has been utilized as a primary pre-LISA sedative in our unit since December 2022, informed consent for this retrospective study was waived.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Data analyzed during this study are included in this published article as supplementary information files. Additional patients\u2019 data are available from the corresponding author on request.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability statement"}},{"value":"Dr Sagee Nissimov and Prof. Iris Morag conceived, designed, and planned the study, contributed to data extraction, and interpretation of results, wrote the first and final draft of the manuscript, and approved the final publication. Drs Amitai Kohn, Rimona Keidar, Ayelet Livne, and NP Mazal Shemer assisted in the extraction of data, and contributed to and approved the final publication. Drs Ayala Gover, Calanit Hershkovich-Shporen and Prof. Matitiahu Berkovitch contributed to study design and data analysis and contributed to and approved the final publication.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}